News Daily News Choosing a DOAC? Apixaban May Have an Edge Over Rivaroxaban Todd Neale March 09, 2020
News Daily News Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk Yael L. Maxwell March 03, 2020
News Daily News Antiplatelets Add Risk in Newly Diagnosed A-fib Patients: GARFIELD-AF Caitlin E. Cox March 02, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights Yael L. Maxwell February 28, 2020
News Conference News ISC 2020 Optimal Time to Start Anticoagulation After Stroke Remains Unclear Todd Neale February 27, 2020
News Conference News CRT 2020 Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR L.A. McKeown February 24, 2020
News Conference News ISET 2020 PERT Data Emerge, Though the Exact Strategy Isn’t a Done Deal Caitlin E. Cox January 30, 2020
News Daily News No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients Todd Neale January 21, 2020
Presentation CACI 2019 ¿Qué papel juegan actualmente los nuevos anticoagulantes en la prevención del stroke? Presenter: Nicolás Gonzalez November 29, 2019